Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Chemours Company (CC)

Chemours Company (CC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,460,058
  • Shares Outstanding, K 150,111
  • Annual Sales, $ 5,808 M
  • Annual Income, $ -386,000 K
  • EBIT $ -64 M
  • EBITDA $ 287 M
  • 60-Month Beta 1.41
  • Price/Sales 0.59
  • Price/Cash Flow 6.89
  • Price/Book 13.56

Options Overview Details

View History
  • Implied Volatility 69.59% (-1.79%)
  • Historical Volatility 59.27%
  • IV Percentile 54%
  • IV Rank 27.02%
  • IV High 140.46% on 11/24/25
  • IV Low 43.35% on 05/14/25
  • Expected Move (DTE 2) 0.91 (3.97%)
  • Put/Call Vol Ratio 0.22
  • Today's Volume 3,049
  • Volume Avg (30-Day) 6,783
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 81,437
  • Open Int (30-Day) 96,517
  • Expected Range 21.98 to 23.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.05
  • Number of Estimates 4
  • High Estimate $0.03
  • Low Estimate $-0.14
  • Prior Year $0.13
  • Growth Rate Est. (year over year) -138.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.36 +31.82%
on 03/16/26
23.20 -1.34%
on 04/13/26
+5.32 (+30.28%)
since 03/13/26
3-Month
14.43 +58.63%
on 01/30/26
23.20 -1.34%
on 04/13/26
+7.93 (+53.01%)
since 01/14/26
52-Week
9.13 +150.71%
on 06/02/25
23.20 -1.34%
on 04/13/26
+11.37 (+98.70%)
since 04/14/25

Most Recent Stories

More News
The Chemours Company Announces Completion of Private Offering of $700,000,000 Aggregate Principal Amount of 7.875% Senior Unsecured Notes Due 2034

WILMINGTON, Del. , March 12, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced it completed its previously announced private offering of $700,000,000 in aggregate principal...

CC : 22.89 (-0.69%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC

NEW YORK , March 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC).  Such investors are advised...

CC : 22.89 (-0.69%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC

NEW YORK , March 5, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised...

CC : 22.89 (-0.69%)
The Chemours Company Announces Upsizing and Pricing of Private Offering of $700,000,000 of 7.875% Senior Notes Due 2034

WILMINGTON, Del. , Feb. 26, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC) today announced the pricing of its previously announced private offering of $700,000,000 aggregate...

CC : 22.89 (-0.69%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Chemours Company - CC

NEW YORK , Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE: CC). Such investors are advised...

CC : 22.89 (-0.69%)
The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2034

WILMINGTON, Del. , Feb. 26, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes...

CC : 22.89 (-0.69%)
Following Successful Fluid Qualification Chemours & 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers & IT Equipment

Successful qualification of Opteon™ fluid in 2CRSi server sparks broader collaboration to drive innovation in new and existing technologies across respective portfolios

CC : 22.89 (-0.69%)
Gabelli Hosts 17th Annual Specialty Chemicals Symposium

GREENWICH, Conn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Specialty Chemicals Symposium in Midtown Manhattan, New York City on Thursday, March 19, 2026. The event will...

ARQ : 2.24 (+5.66%)
CC : 22.89 (-0.69%)
SHW : 333.60 (-0.23%)
LXU : 13.83 (-3.08%)
OEC : 7.08 (+0.85%)
ECL : 273.13 (-0.75%)
LAC : 4.41 (+0.68%)
MTX : 72.86 (-0.21%)
OLN : 28.17 (-4.28%)
SLI : 3.49 (-0.85%)
NGVT : 76.56 (+0.76%)
RYAM : 10.14 (+2.01%)
Chemours' Gerardo Familiar Appointed to SEMI North America Advisory Board

Advanced Performance Materials business president to help guide SEMI's efforts supporting North America's semiconductor innovation and supply chain resilience

CC : 22.89 (-0.69%)
Chemours: Q4 Earnings Snapshot

Chemours: Q4 Earnings Snapshot

CC : 22.89 (-0.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

The Chemours Company offers its customers with solutions across a vast spectrum of industries including plastics and coatings, refrigeration and air conditioning, mining and general industrial manufacturing and electronics. The company's major products include titanium dioxide (TiO2), refrigerants, industrial...

See More

Key Turning Points

3rd Resistance Point 24.03
2nd Resistance Point 23.60
1st Resistance Point 23.24
Last Price 22.89
1st Support Level 22.45
2nd Support Level 22.02
3rd Support Level 21.66

See More

52-Week High 23.20
Last Price 22.89
Fibonacci 61.8% 17.83
Fibonacci 50% 16.17
Fibonacci 38.2% 14.50
52-Week Low 9.13

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.